NeurMedix Obtains FDA Authorization for Pivotal Phase 3 Alzheimer’s Trial

NEXT STORY
HealthCare Partners Expands Relationship with AposHealth® to Bring an Innovative, Non-Invasive Treatment for Knee Osteoarthritis to Members Through a New Delivery Model
PREV STORY
BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP™ System
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19

author_avatar
NASDAQ Market News

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS)

author_avatar
NASDAQ Market News

Predictive Oncology Reports Year End 2020 Financial Results, Provides Business Update

author_avatar
NASDAQ Market News